A study by the Government Accountability Office (GAO) found that some states are slow to complete evaluation reports of Medicaid Section 1115 waivers; Wisconsin Gov. Scott Walker (R) is proposing a $200 million reinsurance program to cover high-cost patients; the House Energy and Commerce subcommittee will hold a hearing on bills containing enforcement-related measures aimed at the opioid crisis.
A study by the Government Accountability Office (GAO) found that some states don’t complete evaluation reports of Medicaid Section 1115 waivers for up to 7 years after the demonstrations begin, thus failing to determine if the experiments are effective, Kaiser Health News reported. GAO also criticized CMS for failing to make the results publicly available quickly, “missing an opportunity to inform federal and state policy discussions,” according to the report. About one-third of Medicaid’s $300 billion annual spending goes to test programs.
Wisconsin Gov. Scott Walker (R) is proposing a $200 million reinsurance program to cover high-cost patients in that state. It’s a turnabout for Walker, who is against the Affordable Care Act (ACA), but he is up for re-election this year. His plan would include some ACA protections for people with pre-existing conditions, Politico reported.
The House Energy and Commerce subcommittee will hold a hearing on February 28 to discuss 8 bills released Thursday regarding enforcement-related measures to help stem the opioid crisis. The Hill reported that the hearing is the first of 3 on opioid legislation. Next Wednesday's hearing will focus on balancing enforcement with patient safety. The bills include steps like expanding access to behavioral health telemedicine in rural areas, updating scheduling guidelines on powerful synthetic opioids, letting hospice workers dispose of unused opioids, and more.
Standard Criteria for Loss of Ambulation Needed in DMD
April 19th 2024A recent study suggests the differences between ambulation definitions for patients with Duchenne muscular dystrophy (DMD) can impact the identification of ambulant vs nonambulant individuals, and standard criteria across settings are needed.
Read More
Overcoming Employment Barriers for Lasting Social Impact: Freedom House 2.0 and Pathways to Work
April 16th 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our second episode, in which we learn all about Freedom House 2.0 and the Pathways to Work program.
Listen
Early Involvement Critical in Treating Immunotherapy-Induced Overlap Syndrome
April 19th 2024A series of case studies reveals the importance of early diagnosis and involvement of special teams of clinicians when dealing with potential cases of overlap syndrome, which encompasses myocarditis, myasthenia gravis, and immune checkpoint inhibitor–related myositis.
Read More
Making Giant Strides in Maternity Health Through Baby Steps
April 9th 2024To help celebrate and recognize National Minority Health Month, we are kicking off a special month-long podcast series with our strategic alliance partner, UPMC Health Plan. Welcome to our first episode, which is all about the Baby Steps Maternity Program and its mission to support women throughout every step of their pregnancy journey.
Listen